Related Experiment Videos
Detection of high-grade restenosis after PTCA using contrast-enhanced electron beam CT
S Achenbach1, W Moshage, K Bachmann
1Department of Internal Medicine II, University of Erlangen-Nürnberg, Erlangen, Germany. stephan.achenbach@stud.uni-erlangen.de
Insights
Electron beam computed tomography (EBCT) can noninvasively detect high-grade restenosis after percutaneous transluminal coronary angioplasty (PTCA). This imaging technique shows high sensitivity for identifying restenosis, aiding in post-procedure patient management.
Area of Science:
- Cardiovascular imaging
- Medical diagnostics
- Interventional cardiology
Background:
- Contrast-enhanced electron beam computed tomography (EBCT) enables noninvasive coronary artery visualization.
- Assessing EBCT's efficacy in detecting high-grade restenosis post-percutaneous transluminal coronary angioplasty (PTCA) is crucial.
Purpose of the Study:
- To evaluate the diagnostic value of EBCT for noninvasively detecting high-grade restenosis after PTCA.
Main Methods:
- Fifty patients underwent EBCT 9 months post-PTCA.
- ECG-gated axial scans with contrast injection were used.
- Three-dimensional reconstructions visualized coronary arteries; results compared with quantitative coronary angiography (QCA).
Main Results:
- EBCT correctly identified high-grade restenosis in 15 of 16 patients (94% sensitivity).
- Specificity for detecting high-grade restenosis was 82% (5 false positives).
- Image quality issues precluded evaluation in 6 patients.
Conclusions:
- EBCT with contrast is effective for noninvasive restenosis diagnosis after PTCA.
- The technique offers high sensitivity and adequate specificity for clinical use.
Background:
Contrast-enhanced electron beam computed tomography (EBCT) has been shown to permit noninvasive visualization of the coronary arteries. We determined the value of EBCT to noninvasively detect high-grade restenosis after percutaneous transluminal coronary angioplasty (PTCA).
Methods And Results:
Fifty patients (37 to 68 years of age), were investigated by EBCT at a mean interval of 9 months after PTCA of coronary artery stenoses. Forty axial cross-sections of the heart (3-mm slice thickness, 1-mm overlap) were acquired triggered to the ECG after intravenous injection of contrast agent. Three-dimensional reconstructions of the coronary arteries were rendered with a lower threshold of 80 HU to selectively visualize the contrast-enhanced vessel lumen. EBCT results were compared with conventional quantitative coronary angiography (QCA) performed within 1 week. In 6 patients, the PTCA segment could not be evaluated because of impaired image quality. Sixteen of the remaining 44 patients had high-grade restenoses in QCA (>70% diameter reduction), which was correctly detected by EBCT in 15 cases (94% sensitivity). There were 5 false-positive EBCT results of high-grade restenosis (82% specificity).
Conclusions:
EBCT with intravenous injection of contrast agent permits the noninvasive diagnosis of restenosis after PTCA, with high sensitivity and sufficient specificity.